Analysis of immunohistochemical stain usage in different pathology practice settings

American Journal of Clinical Pathology

Volumn 138, Issue 6, 2012, Pages 831-836

  Shah, Akeesha A ^a   Frierson, Henry F ^a   Cathro, Helen P ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Academic; Commercial; Immunohistochemistry; Private practice

Indexed keywords

CHROMOGRANIN; CYTOKERATIN 20; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; HIGH MOLECULAR WEIGHT KININOGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA 4 PROTEIN; PROTEIN; PROTEIN P63; SYNAPTOPHYSIN; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; BONE; BREAST; CANCER DIAGNOSIS; CARCINOMA; CHROMOPHOBE CARCINOMA; COMMUNITY HOSPITAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENDOMETRIUM; FEMALE; GASTROINTESTINAL TRACT; GENITAL SYSTEM; HEAD; HEPATOBILIARY SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LUNG; MAJOR CLINICAL STUDY; MALE; NECK; PATHOLOGIST; PATHOLOGY; POORLY DIFFERENTIATED CARCINOMA; PRIORITY JOURNAL; PRIVATE HOSPITAL; PROSTATE; SOFT TISSUE; TRANSITIONAL CELL CARCINOMA; UROGENITAL SYSTEM;

EID: 84869228558     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPAGVTCKDXKK0X     Document Type: Article

References (14)

1. Gossner W. A brief history of the Society for Histochemistry; its founders, its mission and the first 50 years. Histochem Cell Biol. 2002;118:91-94. (Pubitemid 34983966)
2. Wick MR. Histochemistry as a tool in morphological analysis: a historical review. Ann Diagn Pathol. 2012;16:71-78.
3. Williams MJ, Uzman BG. Uses and contributions of diagnostic electron-microscopy in surgical pathology - a study of 20 Veterans Administration hospitals. Hum Pathol. 1984;15:738-745. (Pubitemid 15128328)
4. King JA. Role of transmission electron microscopy in cancer diagnosis and research. Microsc Microanal. 2007;13:20-21.
5. Brandtzaeg P. The increasing power of immunohistochemistry and immunocytochemistry. J Immunol Methods. 1998;216:49-67. (Pubitemid 28440379)
6. Coleman R. The impact of histochemistry: a historical perspective. Acta Histochem. 2000;102:5-14.
7. Jaffer S, Bleiweiss IJ. Beyond hematoxylin and eosin: the role of immunohistochemistry in surgical pathology. Cancer Invest. 2004;22:445-465. (Pubitemid 39310914)
8. Stoward PJ, Nakae Y, Van Noorden CJF. The everchanging advances in enzyme histochemistry, 1986-1996. Eur J Histochem. 1998;42:35-40. (Pubitemid 29096892)
9. Teruya-Feldstein J. The immunohistochemistry laboratory: looking at molecules and preparing for tomorrow. Arch Pathol Lab Med. 2010;134:1659-1665.
10. Cattoretti G. Standardization and reproducibility in diagnostic immunohistochemistry: reply. Hum Pathol. 1994;25:1107-1109.
11. Dacic S, Yousem SA. Molecular testing in lung carcinoma: quo vadis? Am J Clin Pathol. 2010;134:7-9.
12. True LD. Quality control in molecular immunohistochemistry. Histochem Cell Biol. 2008;130:473-480.
13. Wetherington RW, Cooper HS, Al-Saleem T, et al. Clinical significance of performing immunohistochemistry on cases with a previous diagnosis of cancer coming to a national comprehensive cancer center for treatment or second opinion. Am J Surg Pathol. 2002;26:1222-1230. (Pubitemid 34969192)
14. Raab SS. The cost-effectiveness of immunohistochemistry. Arch Pathol Lab Med. 2000;124:1185-1191. (Pubitemid 30650320)